-
AstraZeneca receives two NICE recommendations for lung cancer patients
30 Jan 2025 12:54 GMT
… relative risk of disease recurrence or death by 83% … positive non-small-cell lung cancer after complete tumour resection …
4 Cancer Research UK. Lung cancer mortality statistics. Available at: … NCI Dictionary – Small Cell Lung Cancer. Available at https:/…
-
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
30 Jan 2025 00:02 GMT
… resection for non-small cell lung cancer (NSCLC).
Obesity’s protective … smoking-related toxins.
Lower NSCLC recurrence risk. Obese patients in … lower risk of NSCLC recurrence or death over a … percent lower risk of NSCLC recurrence or death in comparison …
-
Unmet Supportive Care Needs of Lung Cancer Survival Patients at Different Cancer Stages and Treatment Phases
27 Jan 2025 11:14 GMT
… the many different lung cancer treatments currently available, … of lung cancer patients during treatment and recurrence were … subject recruitment focused on lung cancer patients who actively … of advanced lung cancer over a decade. Clin Lung Cancer. 2017 …
-
Looking ahead to wellness
30 Jan 2025 10:17 GMT
… was diagnosed with stage 4 lung cancer.
“I have been receiving treatment … journey, through to treatment, remission, recurrence and end-of-life care …
-
Barriers to Adherence to Standard of Care in Appalachia: A Qualitative Assessment in Gastrointestinal Cancers
29 Jan 2025 16:06 GMT
… system.25–27 In lung cancer, utilization of a navigator … Exploring the experience of recurrence with advanced cancer for … to diagnosis and treatment of lung cancer: a systematic overview of … healthcare system for patients with lung cancer. Clin J Oncol Nurs …
-
Markey home to two breakthrough therapeutic cancer vaccine trials
29 Jan 2025 10:05 GMT
… cancer and nonsmall cell lung cancer — cancer types … risk of recurrence.
Smart vaccine targets lung cancer’s … lung cancer, which represents about 85% of all lung cancer cases. Nonsmall cell lung cancer … and nonsmall cell lung cancer, with outcomes notably …
-
US FDA approves AstraZeneca & Daiichi Sankyo’s Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies
29 Jan 2025 04:34 GMT
… setting or developed disease recurrence during or within six … treatment and experienced disease recurrence within 24 months.
The … setting or developed disease recurrence during or within six … or metastatic non-small cell lung cancer (NSCLC) whose tumours have …
-
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions
28 Jan 2025 23:22 GMT
… advancing precision medicine in lung cancer, panelists examined how … promise of preventing recurrence from happening or … of precision medicine in lung cancer, highlighting the critical … including precision medicine for lung cancer and innovative therapies for …
-
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
28 Jan 2025 11:57 GMT
… -sensitive prostate cancer with biochemical recurrence at high-risk for metastasis … , and thoracic cancers, which includes lung cancer. Driven by science, we are …
-
The Trick With Senolytics
28 Jan 2025 11:02 GMT
… clear senescent cells in advanced lung cancer?
SenoVax consists of patient … tumor models of advanced lung cancer. Treatment led to significant … benefits to patients with advanced lung cancer, melanoma, pancreatic, breast, … lead to resistance or recurrence.